bWell-D Pilot Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Depressive Disorder, MajorCognitive Dysfunction
Interventions
BEHAVIORAL

bWell Cognitive Remediation

"Patients will take part in the bWell cognitive remediation protocol, consisting of 40-minute sessions of bWell, administered 2 times a week for 8 weeks. These sessions consist of tasks that target various cognitive domains and increase in complexity and difficulty as training progresses. The tasks are as follows:~1. Lab Exercise: participant alternates between two different, increasingly complex 'recipes', targeting executive functioning and divided attention.~2. Egg Exercise: In an office environment, participants must seek out and maintain their gaze on certain objects in order to collect them in the presence of visual distractors, targeting sustained attention.~3. Mole Exercise: participants must strike moles with the matching coloured hammer as fast as possible, targeting selective attention.~4. Theatre Exercise: participants must remember objects presented on stage and recreate the sequence after the curtains close, targeting working memory."

BEHAVIORAL

VR Experience

Patients will take part in the viewing of VR scenes which contain no instructed cognitive tasks. This consists of 40-minute sessions of viewing VR scenes, administered 2 times a week for 8 weeks.

All Listed Sponsors
collaborator

Simon Fraser University

OTHER

collaborator

National Research Council, Canada

UNKNOWN

lead

University of British Columbia

OTHER

NCT06546917 - bWell-D Pilot Randomized Controlled Trial | Biotech Hunter | Biotech Hunter